Literature DB >> 18560390

Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis.

Peter Kühnlein1, Hans-Jürgen Gdynia, Anne-Dorte Sperfeld, Beate Lindner-Pfleghar, Albert Christian Ludolph, Mario Prosiegel, Axel Riecker.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease of the motor system. Bulbar symptoms such as dysphagia and dysarthria are frequent features of ALS and can result in reductions in life expectancy and quality of life. These dysfunctions are assessed by clinical examination and by use of instrumented methods such as fiberendoscopic evaluation of swallowing and videofluoroscopy. Laryngospasm, another well-known complication of ALS, commonly comes to light during intubation and extubation procedures in patients undergoing surgery. Laryngeal and pharyngeal complications are treated by use of an array of measures, including body positioning, compensatory techniques, voice and breathing exercises, communication devices, dietary modifications, various safety strategies, and neuropsychological assistance. Meticulous monitoring of clinical symptoms and close cooperation within a multidisciplinary team (physicians, speech and language therapists, occupational therapists, dietitians, caregivers, the patients and their relatives) are vital.

Entities:  

Mesh:

Year:  2008        PMID: 18560390     DOI: 10.1038/ncpneuro0853

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  58 in total

1.  Laryngospasm as preceding symptom of amyotrophic lateral sclerosis.

Authors:  Genevieve Fourcade; Giovanni Castelnovo; Dimitri Renard; Pierre Labauge
Journal:  J Neurol       Date:  2010-06-22       Impact factor: 4.849

Review 2.  [Neurogenic dysphagia].

Authors:  R Wirth; R Dziewas
Journal:  Internist (Berl)       Date:  2017-02       Impact factor: 0.743

3.  Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia.

Authors:  S Tamburrini; A Solazzo; A Sagnelli; L Del Vecchio; A Reginelli; M Monsorrò; R Grassi
Journal:  Radiol Med       Date:  2010-02-19       Impact factor: 3.469

4.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

5.  [FEES for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German Stroke Society].

Authors:  R Dziewas; J Glahn; C Helfer; G Ickenstein; J Keller; S Lapa; C Ledl; B Lindner-Pfleghar; D Nabavi; M Prosiegel; A Riecker; S Stanschus; T Warnecke; O Busse
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

6.  [Age-related changes in swallowing. Physiology and pathophysiology].

Authors:  P Muhle; R Wirth; J Glahn; R Dziewas
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

Review 7.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

8.  The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States.

Authors:  Emily K Plowman; Lauren C Tabor; James Wymer; Gary Pattee
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-20       Impact factor: 4.092

9.  Intralingual Administration of AAVrh10-miRSOD1 Improves Respiratory But Not Swallowing Function in a Superoxide Dismutase-1 Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Lori A Lind; Ellyn M Andel; Angela L McCall; Justin S Dhindsa; Katherine A Johnson; Olivia E Stricklin; Christian Mueller; Mai K ElMallah; Teresa E Lever; Nicole L Nichols
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 5.695

10.  Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.

Authors:  E K Plowman; L C Tabor; R Robison; J Gaziano; C Dion; S A Watts; T Vu; C Gooch
Journal:  Neurogastroenterol Motil       Date:  2015-10-28       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.